CN103980295A - 一类可修饰的荧光化合物,合成方法及其作为近红外二区报告分子的用途 - Google Patents
一类可修饰的荧光化合物,合成方法及其作为近红外二区报告分子的用途 Download PDFInfo
- Publication number
- CN103980295A CN103980295A CN201410221459.4A CN201410221459A CN103980295A CN 103980295 A CN103980295 A CN 103980295A CN 201410221459 A CN201410221459 A CN 201410221459A CN 103980295 A CN103980295 A CN 103980295A
- Authority
- CN
- China
- Prior art keywords
- reaction
- compound
- modifiable
- add
- nitrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007850 fluorescent dye Substances 0.000 title abstract description 7
- 238000001308 synthesis method Methods 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 44
- 150000001875 compounds Chemical class 0.000 claims abstract description 37
- 238000000338 in vitro Methods 0.000 claims abstract description 6
- 238000011503 in vivo imaging Methods 0.000 claims abstract description 6
- 238000002360 preparation method Methods 0.000 claims abstract 5
- 238000006243 chemical reaction Methods 0.000 claims description 153
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 144
- 229910052757 nitrogen Inorganic materials 0.000 claims description 75
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 54
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 48
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 36
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 claims description 24
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 20
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 16
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 16
- 238000010438 heat treatment Methods 0.000 claims description 16
- 229910052760 oxygen Inorganic materials 0.000 claims description 16
- 239000001301 oxygen Substances 0.000 claims description 16
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims description 16
- 238000010992 reflux Methods 0.000 claims description 16
- 238000003756 stirring Methods 0.000 claims description 16
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- 239000005051 trimethylchlorosilane Substances 0.000 claims description 12
- 239000000523 sample Substances 0.000 claims description 11
- 229960000583 acetic acid Drugs 0.000 claims description 10
- 239000012362 glacial acetic acid Substances 0.000 claims description 10
- 239000011261 inert gas Substances 0.000 claims description 10
- 230000035484 reaction time Effects 0.000 claims description 10
- 239000007789 gas Substances 0.000 claims description 8
- 238000010907 mechanical stirring Methods 0.000 claims description 8
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 8
- 229940125782 compound 2 Drugs 0.000 claims description 6
- 229940126214 compound 3 Drugs 0.000 claims description 6
- 239000004327 boric acid Substances 0.000 claims description 4
- 229940125898 compound 5 Drugs 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- CMQCNTNASCDNGR-UHFFFAOYSA-N toluene;hydrate Chemical compound O.CC1=CC=CC=C1 CMQCNTNASCDNGR-UHFFFAOYSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- -1 boric acid ester Chemical group 0.000 claims description 2
- 125000005619 boric acid group Chemical group 0.000 claims description 2
- AICOOMRHRUFYCM-ZRRPKQBOSA-N oxazine, 1 Chemical compound C([C@@H]1[C@H](C(C[C@]2(C)[C@@H]([C@H](C)N(C)C)[C@H](O)C[C@]21C)=O)CC1=CC2)C[C@H]1[C@@]1(C)[C@H]2N=C(C(C)C)OC1 AICOOMRHRUFYCM-ZRRPKQBOSA-N 0.000 claims description 2
- 238000000746 purification Methods 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- OBISXEJSEGNNKL-UHFFFAOYSA-N dinitrogen-n-sulfide Chemical group [N-]=[N+]=S OBISXEJSEGNNKL-UHFFFAOYSA-N 0.000 abstract description 4
- 230000003287 optical effect Effects 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 238000013399 early diagnosis Methods 0.000 abstract description 3
- 238000011156 evaluation Methods 0.000 abstract description 3
- 230000002980 postoperative effect Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 57
- 239000000243 solution Substances 0.000 description 48
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 36
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 36
- 239000012074 organic phase Substances 0.000 description 36
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 24
- 239000007806 chemical reaction intermediate Substances 0.000 description 24
- 238000001035 drying Methods 0.000 description 24
- 239000000706 filtrate Substances 0.000 description 24
- 206010028980 Neoplasm Diseases 0.000 description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 229910052786 argon Inorganic materials 0.000 description 18
- 238000000605 extraction Methods 0.000 description 18
- 229910002027 silica gel Inorganic materials 0.000 description 18
- 239000000741 silica gel Substances 0.000 description 18
- 229960001866 silicon dioxide Drugs 0.000 description 18
- 201000011510 cancer Diseases 0.000 description 16
- 239000000543 intermediate Substances 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- 239000011259 mixed solution Substances 0.000 description 12
- 239000012071 phase Substances 0.000 description 12
- 239000000975 dye Substances 0.000 description 11
- 238000000799 fluorescence microscopy Methods 0.000 description 11
- 238000003384 imaging method Methods 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 229960004657 indocyanine green Drugs 0.000 description 7
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000006837 decompression Effects 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000002109 single walled nanotube Substances 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002041 carbon nanotube Substances 0.000 description 3
- 229910021393 carbon nanotube Inorganic materials 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 230000004304 visual acuity Effects 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 230000010748 Photoabsorption Effects 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- WPYVAWXEWQSOGY-UHFFFAOYSA-N indium antimonide Chemical compound [Sb]#[In] WPYVAWXEWQSOGY-UHFFFAOYSA-N 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000002603 single-photon emission computed tomography Methods 0.000 description 1
- 230000000192 social effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
- C09K2211/1037—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom with sulfur
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410221459.4A CN103980295B (zh) | 2014-05-23 | 2014-05-23 | 一类可修饰的荧光化合物,合成方法及其作为近红外二区报告分子的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410221459.4A CN103980295B (zh) | 2014-05-23 | 2014-05-23 | 一类可修饰的荧光化合物,合成方法及其作为近红外二区报告分子的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103980295A true CN103980295A (zh) | 2014-08-13 |
CN103980295B CN103980295B (zh) | 2016-03-30 |
Family
ID=51272488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410221459.4A Active CN103980295B (zh) | 2014-05-23 | 2014-05-23 | 一类可修饰的荧光化合物,合成方法及其作为近红外二区报告分子的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103980295B (zh) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106977529A (zh) * | 2017-02-24 | 2017-07-25 | 武汉振豪生物科技有限公司 | 一类可修饰的近红外二区荧光成像探针及其制备方法和用途 |
CN109336909A (zh) * | 2018-11-07 | 2019-02-15 | 武汉大学深圳研究院 | 具有聚集诱导发光性质的近红外二区荧光化合物及制备方法、纳米粒胶束及其应用 |
CN109369633A (zh) * | 2018-11-30 | 2019-02-22 | 武汉大学 | 一种可靶向线粒体的近红外二区荧光化合物及其制备方法与应用 |
CN111068073A (zh) * | 2018-10-18 | 2020-04-28 | 华中师范大学 | 近红外二区荧光造影剂及其制备方法和应用 |
CN111362971A (zh) * | 2020-03-16 | 2020-07-03 | 北京师范大学 | 靶向psma的双苯并噻二唑类化合物及其制备方法与应用 |
WO2020239025A1 (en) * | 2019-05-28 | 2020-12-03 | The Hong Kong University Of Science And Technology | An ultrabright nir-ii aiegen for bioimaging |
CN113214293A (zh) * | 2020-01-21 | 2021-08-06 | 香港科技大学 | 一种近红外二区聚集诱导发光荧光化合物、及其制备方法和用途 |
CN114409710A (zh) * | 2022-01-19 | 2022-04-29 | 西藏大学 | Nir-ii多吡啶钌配合物及其制备方法和应用 |
CN114478581A (zh) * | 2022-01-05 | 2022-05-13 | 西藏大学 | 光治疗的nir-ii小分子、化合物、配合物及其制备方法和应用 |
CN114716470A (zh) * | 2022-04-27 | 2022-07-08 | 中国科学院上海药物研究所 | 不对称的供体-受体型近红外二区探针分子及其制备方法和应用 |
CN114751918A (zh) * | 2022-05-07 | 2022-07-15 | 深圳大学 | 新型近红外二区激发聚集诱导发光材料及制备方法、应用 |
CN114805396A (zh) * | 2021-01-28 | 2022-07-29 | 武汉大学深圳研究院 | 可调控代谢的有机荧光小分子化合物及其制备方法和应用 |
CN114805397A (zh) * | 2021-01-28 | 2022-07-29 | 武汉大学 | 可在体内长时间循环的有机荧光小分子化合物及其制备方法和应用 |
CN114853787A (zh) * | 2022-04-13 | 2022-08-05 | 河南大学 | 一种近红外二区aie分子探针及其制备方法和应用 |
CN115557973A (zh) * | 2021-07-02 | 2023-01-03 | 武汉大学 | 具有聚集诱导发光性质的近红外二区荧光化合物及其制备方法和应用 |
CN115557971A (zh) * | 2021-07-02 | 2023-01-03 | 武汉大学深圳研究院 | 1500nm以上成像的有机荧光小分子化合物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101280187A (zh) * | 2008-05-16 | 2008-10-08 | 华南理工大学 | 可溶性电子传输型电致红光材料及其制备方法与应用 |
JP2009104976A (ja) * | 2007-10-25 | 2009-05-14 | Konica Minolta Business Technologies Inc | 光電変換素子、及び太陽電池 |
CN101899021A (zh) * | 2010-07-16 | 2010-12-01 | 中国科学院上海微系统与信息技术研究所 | 一类荧光化合物及其在检测痕量甲基苯丙胺中的应用 |
-
2014
- 2014-05-23 CN CN201410221459.4A patent/CN103980295B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009104976A (ja) * | 2007-10-25 | 2009-05-14 | Konica Minolta Business Technologies Inc | 光電変換素子、及び太陽電池 |
CN101280187A (zh) * | 2008-05-16 | 2008-10-08 | 华南理工大学 | 可溶性电子传输型电致红光材料及其制备方法与应用 |
CN101899021A (zh) * | 2010-07-16 | 2010-12-01 | 中国科学院上海微系统与信息技术研究所 | 一类荧光化合物及其在检测痕量甲基苯丙胺中的应用 |
Non-Patent Citations (2)
Title |
---|
ANUP THOMAS等: "Near infrared absorbing benzobis(thiadiazole) derivatives: computational studies point to biradical nature of the ground states", 《JOURNAL OF PHYSICAL AND ORGANIC CHEMISTRY》 * |
DONGMEI WANG,等: "Density functional theory design and characterization of D–A–A type electron donors with narrow band gap for small-molecule organic solar cells", 《COMPUTATIONAL AND THEORETICAL CHEMISTRY》 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106977529A (zh) * | 2017-02-24 | 2017-07-25 | 武汉振豪生物科技有限公司 | 一类可修饰的近红外二区荧光成像探针及其制备方法和用途 |
CN111068073B (zh) * | 2018-10-18 | 2022-07-05 | 华中师范大学 | 近红外二区荧光造影剂及其制备方法和应用 |
CN111068073A (zh) * | 2018-10-18 | 2020-04-28 | 华中师范大学 | 近红外二区荧光造影剂及其制备方法和应用 |
CN109336909A (zh) * | 2018-11-07 | 2019-02-15 | 武汉大学深圳研究院 | 具有聚集诱导发光性质的近红外二区荧光化合物及制备方法、纳米粒胶束及其应用 |
CN109369633A (zh) * | 2018-11-30 | 2019-02-22 | 武汉大学 | 一种可靶向线粒体的近红外二区荧光化合物及其制备方法与应用 |
CN113853376B (zh) * | 2019-05-28 | 2024-02-06 | 香港科技大学 | 一种用于生物成像的超亮nir-ii aie发光体 |
CN113853376A (zh) * | 2019-05-28 | 2021-12-28 | 香港科技大学 | 一种用于生物成像的超亮nir-ii aie发光体 |
WO2020239025A1 (en) * | 2019-05-28 | 2020-12-03 | The Hong Kong University Of Science And Technology | An ultrabright nir-ii aiegen for bioimaging |
CN113214293A (zh) * | 2020-01-21 | 2021-08-06 | 香港科技大学 | 一种近红外二区聚集诱导发光荧光化合物、及其制备方法和用途 |
CN111362971B (zh) * | 2020-03-16 | 2021-02-09 | 北京师范大学 | 靶向psma的双苯并噻二唑类化合物及其制备方法与应用 |
CN111362971A (zh) * | 2020-03-16 | 2020-07-03 | 北京师范大学 | 靶向psma的双苯并噻二唑类化合物及其制备方法与应用 |
CN114805396A (zh) * | 2021-01-28 | 2022-07-29 | 武汉大学深圳研究院 | 可调控代谢的有机荧光小分子化合物及其制备方法和应用 |
CN114805396B (zh) * | 2021-01-28 | 2023-10-31 | 武汉大学深圳研究院 | 可调控代谢的有机荧光小分子化合物及其制备方法和应用 |
CN114805397A (zh) * | 2021-01-28 | 2022-07-29 | 武汉大学 | 可在体内长时间循环的有机荧光小分子化合物及其制备方法和应用 |
CN115557971A (zh) * | 2021-07-02 | 2023-01-03 | 武汉大学深圳研究院 | 1500nm以上成像的有机荧光小分子化合物及其制备方法和应用 |
CN115557973A (zh) * | 2021-07-02 | 2023-01-03 | 武汉大学 | 具有聚集诱导发光性质的近红外二区荧光化合物及其制备方法和应用 |
CN115557973B (zh) * | 2021-07-02 | 2024-02-02 | 武汉大学 | 具有聚集诱导发光性质的近红外二区荧光化合物及其制备方法和应用 |
CN115557971B (zh) * | 2021-07-02 | 2024-02-02 | 武汉大学深圳研究院 | 1500nm以上成像的有机荧光小分子化合物及其制备方法和应用 |
CN114478581B (zh) * | 2022-01-05 | 2023-04-07 | 西藏大学 | 光治疗的nir-ii小分子、化合物、配合物及其制备方法和应用 |
CN114478581A (zh) * | 2022-01-05 | 2022-05-13 | 西藏大学 | 光治疗的nir-ii小分子、化合物、配合物及其制备方法和应用 |
CN114409710B (zh) * | 2022-01-19 | 2024-01-09 | 西藏大学 | Nir-ii多吡啶钌配合物及其制备方法和应用 |
CN114409710A (zh) * | 2022-01-19 | 2022-04-29 | 西藏大学 | Nir-ii多吡啶钌配合物及其制备方法和应用 |
CN114853787A (zh) * | 2022-04-13 | 2022-08-05 | 河南大学 | 一种近红外二区aie分子探针及其制备方法和应用 |
CN114853787B (zh) * | 2022-04-13 | 2023-06-06 | 河南大学 | 一种近红外二区aie分子探针及其制备方法和应用 |
CN114716470A (zh) * | 2022-04-27 | 2022-07-08 | 中国科学院上海药物研究所 | 不对称的供体-受体型近红外二区探针分子及其制备方法和应用 |
CN114716470B (zh) * | 2022-04-27 | 2024-04-26 | 中国科学院上海药物研究所 | 不对称的供体-受体型近红外二区探针分子及其制备方法和应用 |
CN114751918A (zh) * | 2022-05-07 | 2022-07-15 | 深圳大学 | 新型近红外二区激发聚集诱导发光材料及制备方法、应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103980295B (zh) | 2016-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103980295B (zh) | 一类可修饰的荧光化合物,合成方法及其作为近红外二区报告分子的用途 | |
Zhen et al. | The development of phosphorescent probes for in vitro and in vivo bioimaging | |
Yue et al. | Red-emissive ruthenium-containing carbon dots for bioimaging and photodynamic cancer therapy | |
Yi et al. | Lanthanide-activated nanoparticles: a toolbox for bioimaging, therapeutics, and neuromodulation | |
Qi et al. | Aggregation-induced emission luminogen with near-infrared-II excitation and near-infrared-I emission for ultradeep intravital two-photon microscopy | |
Guan et al. | Near-infrared triggered upconversion polymeric nanoparticles based on aggregation-induced emission and mitochondria targeting for photodynamic cancer therapy | |
Li et al. | Management of fluorescent organic/inorganic nanohybrids for biomedical applications in the NIR-II region | |
Lemercier et al. | Two-photon absorption properties of 1, 10-phenanthroline-based Ru (II) complexes and related functionalized nanoparticles for potential application in two-photon excitation photodynamic therapy and optical power limiting | |
Alberti | From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy | |
Zhang et al. | Monomolecular multimodal fluorescence-radioisotope imaging agents | |
CN107469079B (zh) | 一种t1-mri成像引导下的光动治疗剂制备方法 | |
Dang et al. | Organic fluorescent nanoparticles with NIR-II emission for bioimaging and therapy | |
Shen et al. | Stimuli‐responsive organic near‐infrared photoacoustic probes | |
CN104483296B (zh) | 乳腺癌分子探针及其制造方法 | |
Xu et al. | When near-infrared fluorescence meets supramolecular coordination complexes: Challenges and opportunities of metallacycles/metallacages in precision biomedicine | |
Yao et al. | Nonaromatic organonickel (II) phototheranostics | |
Liu et al. | Optical–magnetic probe for evaluating cancer therapy | |
CN103550162B (zh) | 具有靶向性四氧化三铁-卟啉复合纳米粒子的制备方法 | |
Wu et al. | Recent advances in the development and applications of conjugated polymer dots | |
CN104587485A (zh) | 替拉扎明-金纳米粒子复合物制备方法及其应用 | |
Jiang et al. | Design and application of organic contrast agents for molecular imaging in the second near infrared (NIR-II) window | |
Sun et al. | advances in the application of microenvironment-responsive NIR-II fluorescent probes in organisms | |
CN111544588A (zh) | 一类免疫活性肽-胆绿素的缀合物、其制备方法及应用 | |
Liu et al. | Aggregation-induced emission shining in the biomedical field: From bench to bedside | |
CN104383543A (zh) | 手性纳米硒材料负载siRNA在制备抗肿瘤药物的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180521 Address after: 430000 Jianghan Road, Jianghan District, Jianghan District, Wuhan, Hubei, 6, Hankou Patentee after: WUHAN LVHAIZONG BIOTECHNOLOGY CO.,LTD. Address before: 430072 Wuhan University, Luojia mountain, Wuchang District, Wuhan, Hubei Patentee before: Wuhan University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240403 Address after: No. 185 Donghu Road, Wuchang District, Wuhan City, Hubei Province, 430072 Patentee after: Hong Xuechuan Country or region after: China Address before: 430000 Jianghan Road, Jianghan District, Jianghan District, Wuhan, Hubei, 6, Hankou Patentee before: WUHAN LVHAIZONG BIOTECHNOLOGY CO.,LTD. Country or region before: China |